• Medientyp: E-Artikel
  • Titel: Randomly positioned gold nanoparticles as fluorescence enhancers in apta-immunosensor for malaria test
  • Beteiligte: Minopoli, Antonio [VerfasserIn]; Della Ventura, Bartolomeo [VerfasserIn]; Campanile, Raffaele [VerfasserIn]; Tanner, Julian A. [VerfasserIn]; Offenhäusser, Andreas [VerfasserIn]; Mayer, Dirk [VerfasserIn]; Velotta, Raffaele [VerfasserIn]
  • Erschienen: Springer, 2021
  • Erschienen in: Microchimica acta 188(3), 88 (2021). doi:10.1007/s00604-021-04746-9
  • Sprache: Englisch
  • DOI: https://doi.org/10.1007/s00604-021-04746-9
  • ISSN: 1436-5073; 0344-838X; 0369-2795; 0026-3672; 0369-0504; 0344-8436
  • Entstehung:
  • Anmerkungen: Diese Datenquelle enthält auch Bestandsnachweise, die nicht zu einem Volltext führen.
  • Beschreibung: A plasmon-enhanced fluorescence-based antibody-aptamer biosensor — consisting of gold nanoparticles randomly immobilized onto a glass substrate via electrostatic self-assembly — is described for specific detection of proteins in whole blood. Analyte recognition is realized through a sandwich scheme with a capture bioreceptor layer of antibodies — covalently immobilized onto the gold nanoparticle surface in upright orientation and close-packed configuration by photochemical immobilization technique (PIT) — and a top bioreceptor layer of fluorescently labelled aptamers. Such a sandwich configuration warrants not only extremely high specificity, but also an ideal fluorophore-nanostructure distance (approximately 10–15 nm) for achieving strong fluorescence amplification. For a specific application, we tested the biosensor performance in a case study for the detection of malaria-related marker Plasmodium falciparum lactate dehydrogenase (PfLDH). The proposed biosensor can specifically detect PfLDH in spiked whole blood down to 10 pM (0.3 ng/mL) without any sample pretreatment. The combination of simple and scalable fabrication, potentially high-throughput analysis, and excellent sensing performance provides a new approach to biosensing with significant advantages compared to conventional fluorescence immunoassays
  • Zugangsstatus: Freier Zugang